Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Wayland Group Corp MRRCF

Healthcare Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Cannabis
Wayland Group Corp, formerly Maricann Group Inc produces and sells medical marijuana. It is currently engaged in cultivation, extraction, analytics and production facilities to elevate offerings and prepare for growth into the adult-use cannabis market in Canada.


GREY:MRRCF - Post by User

Wayland Group Corp
Bullboard Posts
User Avatar Image
(17)
•••
Comment by Longterm777on Mar 06, 2019 12:45am
97 Views
Post# 29447718

RE:My lesson learned from Wayland.

RE:My lesson learned from Wayland. Anyone who disagrees that BEn should be removed from the CEO role is plain foolish.  His lying about fully funded, revenue projections and his general inability to deliver on anything should be clear sign.  Ben’s capital market knowledge is terrible.  He has consistently raised funds  lower and lower.  This latest raise was the lowest yet...next,  he will raise funds under a buck if he is still the CEO.  

The investment community has spoken by driving the share price to sub 1 dollar while many other cannabis stocks are pushing forward. 


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities